http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-5550435-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-46
filingDate 2005-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6e98a66ecaecc786e0dbe95e9db3708
publicationDate 2005-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CO-5550435-A2
titleOfInvention TIAZOL COMPOUNDS FOR THE TREATMENT OF NEU-RODEGENERATIVE DISORDERS
abstract 1.- A compound, or its pharmaceutically acceptable salts, of the formula: in which: A is selected from the moieties -C (= O) C (= O) -, - (C = O) NR9-, -C ( = O) Z-, -C (= S) Z-, -C (= NR5) Z-, and -S (O) 2-; in which Z is a residue -CH2-, a residue -CH (OH ) -, a residue -CH (OC (= O) R11) -, a residue -CH (NR9R10) -, a residue CH (CH2 (OH)) -, a residue -CH (CH (C1-C4 alkyl) (OH)) -, or a moiety -CH (C (C1-C4 alkyl) (C1-C4 alkyl) (OH)) -; R1 is selected from a C1-C20 alkyl moiety and an -alkoxy moiety of C1-C20, a C3-C8 cycloalkyl moiety, a (C4-C8) cycloalkenyl moiety, a bi-or tricycloalkyl moiety of (C5-C11), a bi-or tricycloalkenyl moiety of (C7-C11), a moiety heterocycloalkyl (3-8 members), an aryl (C6-C14) moiety, or a heteroaryl (5-14 members) moiety, wherein said alkyl and alkoxy moieties optionally each contain one to five doubles or triples bonds, and wherein each hydrogen atom of said alkyl and alkoxy groups is optionally replaced with an atom of fluorine; in which when R1 is an alkyl or alkoxy group, R1 is optionally substituted with one to three substituents R1a, and in which when R1 is a cycloalkyl, cycloalkenyl, bi- or tricycloalkyl, bi- or tricycloalkenyl, heterocycloalkyl group , aryl, or heteroaryl, then R1 is optionally substituted with one to three substituents R1b; R1a is independently selected in each case from the moieties -OH, -C1-C6 alkyl which independently and optionally contains from one to three doubles or triples links, -C1-C6 alkoxy that independently and optionally contains one to three double or triple bonds, -Cl, -F, -Br, -I, -CN, -NO2, -NR9R10, -C (= O) NR9R10 , -S (O) nNR9R10, C (= O) R11, -S (O) nR11, -C (= O) OR12, -C3-C8 cycloalkyl, C4-C8 cycloalkenyl, -bi- or -cycloalkyl of (C5-C11), -bi- or -trichloralkenyl of (C7-C11), heterocycloalkyl (3-8 members), -aryl (C6-C14), heteroaryl (5-14 members), -aryloxy of ( C6-C14), and -heteroaryloxy (5-14 member s), wherein said alkyl, alkoxy, cycloalkyl, cycloalkenyl, bi- or tricycloalkyl, bi- or tricycloalkenyl, heterocycloalkyl, aryl, ... groups
priorityDate 2002-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562

Total number of triples: 40.